Area of research
Oncology · Surgery
Research interest
Research interests include Colorectal Cancer Surgical Treatments, Colorectal and Anal Carcinomas, Colorectal Cancer Treatments and Studies, and Genetic factors in colorectal cancer.
Tumor-informed circulating tumor DNA stratifies recurrence risk and survival in anal squamous cell carcinoma.
Progressive plasticity during colorectal cancer metastasis.
Correlation Between Grade of Clinical Response to Neoadjuvant Therapy for Rectal Cancer and Oncologic Outcomes in the Era of Watch-and-Wait.
Author Correction: Progressive plasticity during colorectal cancer metastasis
Impact of Patient-Reported Outcome Monitoring via Recovery Tracker on Post-Discharge Outcomes After Colorectal Surgery: A Comparative Analysis Before and After Implementation.
Author Correction: Progressive plasticity during colorectal cancer metastasis.
Risk of Residual Cancer After Immediate Surgery or Nonoperative Management After Malignant Colorectal Polypectomy With High-Risk Features
Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial.
Progressive plasticity during colorectal cancer metastasis
MRI Predicts Residual Disease and Outcomes in Watch-and-Wait Patients with Rectal Cancer
Watch and wait in rectal cancer patients with residual mucin on magnetic resonance imaging following neoadjuvant therapy
Colonic Adenosquamous Carcinoma: A Single-Center Review of Patient Clinicopathologic Characteristics, Genetics, and Clinical Outcomes.
Clinical Calculator for Predicting Freedom From Recurrence After Resection of Stage I-III Colon Cancer in Patients With Microsatellite Instability.
Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial
Incomplete cytoreductive surgery for appendiceal and colorectal peritoneal carcinomatosis: Characteristics and outcomes of an overlooked group.
Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy
Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy.
Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer
Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer.
Disruption of the crypt niche promotes outgrowth of mutated colorectal tumor stem cells
An immunocompetent rectal cancer model to study radiation therapy
Clinical Calculator Based on Molecular and Clinicopathologic Characteristics Predicts Recurrence Following Resection of Stage I-III Colon Cancer.
KRAS mutant rectal cancer cells interact with surrounding fibroblasts to deplete the extracellular matrix
A rectal cancer organoid platform to study individual responses to chemoradiation
Organoids Reveal That Inherent Radiosensitivity of Small and Large Intestinal Stem Cells Determines Organ Sensitivity
Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis
SMAD4 Loss in Colorectal Cancer Patients Correlates with Recurrence, Loss of Immune Infiltrate, and Chemoresistance
Logarithmic expansion of LGR5 + cells in human colorectal cancer
Distinct Levels of Radioresistance in Lgr5+ Colonic Epithelial Stem Cells versus Lgr5+ Small Intestinal Stem Cells